The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.

Front Mol Biosci · 2021 · PMC8425476 · PMID 34513923

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Similarly, the mRNA expression level of Acta2 had a decreasing trend in IFM-treated MCD-fed ApoE -/- mice ( Figure 5C ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.